{"id":"placebo-for-limaprost","safety":{"commonSideEffects":[]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Placebo serves as a control comparator in clinical trials and has no direct molecular or therapeutic mechanism of action. Any observed effects are attributable to placebo response (psychological and contextual factors) rather than pharmacological activity. In the context of this trial, placebo was used as a comparator arm to evaluate the efficacy of Limaprost.","oneSentence":"Placebo is an inert substance with no active pharmacological mechanism.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:01:00.219Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[]},"trialDetails":[{"nctId":"NCT04876612","phase":"NA","title":"Effect of Limaprost in Combination With Transforaminal Epidural Steroid Injection","status":"RECRUITING","sponsor":"Seoul National University","startDate":"2021-11-10","conditions":"Lumbar Spinal Stenosis","enrollment":104},{"nctId":"NCT02125981","phase":"PHASE3","title":"The Study About the Efficacy of Oral Limaprost After Surgery for Cervical Myelopathy","status":"COMPLETED","sponsor":"Seoul National University Hospital","startDate":"2014-09-01","conditions":"Cervical Myelopathy","enrollment":160},{"nctId":"NCT01888536","phase":"PHASE4","title":"A Study to Evaluate Efficacy of 『Opast Tablet』for Neurologic Claudication in Patients With Lumbar Spinal Stenosis","status":"COMPLETED","sponsor":"Yungjin Pharm. Co., Ltd.","startDate":"2013-02","conditions":"Neurologic Claudication in Patients With Lumbar Spinal Stenosis","enrollment":182}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Placebo(for Limaprost)","genericName":"Placebo(for Limaprost)","companyName":"Yungjin Pharm. Co., Ltd.","companyId":"yungjin-pharm-co-ltd","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":true,"score":2}}